Psychometric Evaluation of the Chinese Version of the Resilience Scale-10 for Cancer Children
1 other identifier
observational
186
1 country
1
Brief Summary
This study aims to translate the original English version of Resilience Scale for Children (RS10) into traditional Chinese. It will then test the psychometric properties of the newly translated RS10.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2018
CompletedFirst Submitted
Initial submission to the registry
May 18, 2018
CompletedFirst Posted
Study publicly available on registry
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 29, 2021
November 1, 2020
2.8 years
May 18, 2018
April 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Resilience level
The Resilience Scale for Children (RS10) was developed to measure a child's capacity to respond to the life changes. The RS10 measures the child's resilience capacity along five core elements: (1) Sense of purpose and meaning, (2) Authenticity, (3) Equanimity, (4) Self-Reliance, and (5) Perseverance.
Baseline
Secondary Outcomes (2)
Number of depressive symptoms
Baseline
Levels of self-esteem
Baseline
Eligibility Criteria
Children should be ages between 7 and 14; diagnosed with cancer within the previous 6 months and currently undergoing active treatments, and able to speak Cantonese and read Chinese.
You may qualify if:
- ages between 7 and 14;
- diagnosed with cancer within the previous 6 months and currently undergoing active treatments;
- able to speak Cantonese and read Chinese.
You may not qualify if:
- \- Those children with cognitive and learning problems identified from their medical records will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Hong Kong
Hong Kong, Hong Kong
Related Publications (1)
Chung JOK, Li WHC, Wei X, Cheung AT, Ho LLK, Chan GC. Translation and psychometric evaluation of the Chinese version of the resilience scale for children with cancer. Health Qual Life Outcomes. 2021 Oct 2;19(1):232. doi: 10.1186/s12955-021-01865-y.
PMID: 34600543DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Oi Kwan Joyce Chung, Dr
The University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2018
First Posted
June 1, 2018
Study Start
February 28, 2018
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
April 29, 2021
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share